3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients3D Bio Therapeutics, Inc. 3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients November 19, 2019Kevin Slawin2019-11-20T10:14:12-06:00November 19th, 2019|Share This Story, Choose Your Platform!FacebookTwitterLinkedInRedditWhatsappTumblrPinterestVkEmail About the Author: Kevin Slawin Related Posts Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment.
Leave A Comment